Hub : Traits :

Hearing difficulty/problems: Yes

38 significantly associated models · 20 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	45393277	46782409	1	1	2.5e-07	1.4e-06	0.3400	96	CCDC17
2	2	42753863	44149442	1	1	6.9e-08	1.7e-05	0.1850	90	ZFP36L2
3	5	72162264	73934274	4	7	2.9e-16	1.4e-19	NaN	NaN	ANKRA2 ARHGEF28 RGNEF UTP15
4	5	147825590	149338157	1	1	6.0e-08	2.1e-07	1.0000	100	ABLIM3
5	6	42611872	44034691	2	1	5.4e-13	1.3e-14	0.0067	88	ZNF318
6	8	140969818	142706843	1	1	7.3e-08	6.4e-08	0.0159	80	PTK2
7	10	75189586	76603535	1	1	9.0e-08	5.5e-06	0.4600	97	AP3M1
8	11	117732806	119353188	4	1	9.0e-11	3.0e-10	1.0000	100	DDX6
9	12	109295508	110704487	1	1	5.4e-08	3.1e-07	1.0000	100	MMAB
10	17	6469505	7863344	1	1	2.9e-07	1.2e-06	0.1440	91	CLDN7
11	18	52324675	52873317	1	1	9.4e-08	4.0e-08	0.0961	91	CCDC68
12	19	19391402	19892796	1	1	1.1e-07	3.2e-06	0.2010	92	YJEFN3
13	19	52150601	52657049	1	1	3.1e-07	1.4e-04	0.1910	88	ZNF649

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	1.21	1	0	0.0	0.00	1.0e+00	YJEFN3
Depressed Affect (Nagel 2018)	2.15	4	0	0.0	0.52	4.8e-01	DDX6 MMAB PTK2 ZNF318
Intelligence (Savage-Jansen 2018)	0.68	1	0	0.0	0.00	1.0e+00	PTK2
Neuroticism (Nagel 2018)	2.69	3	1	2.2	0.00	1.0e+00	DDX6 MMAB ZNF318
Schizophrenia vs Biploar Disorder	2.30	1	0	0.0	0.00	1.0e+00	PTK2
Worry (Nagel 2018)	1.82	2	1	2.2	0.00	1.0e+00	MMAB ZNF318
Crohns Disease (2017)	1.21	1	0	0.0	0.00	1.0e+00	AP3M1
Irritable Bowel Disease (IBD)	1.16	2	0	0.0	0.00	1.0e+00	AP3M1 CCDC17
Ulcerative Colitis (UC)	0.87	1	0	0.0	0.00	1.0e+00	CCDC17
Reaction Time	1.53	2	0	0.0	0.00	1.0e+00	AP3M1 CLDN7
Breast Cancer	1.58	3	0	0.0	0.00	1.0e+00	CCDC17 CLDN7 YJEFN3
Age at First Birth	1.33	1	0	0.0	0.00	1.0e+00	PTK2
HDL Cholesterol	2.04	1	1	2.2	0.00	1.0e+00	MMAB
Rheumatoid Arthritis	1.77	1	0	0.0	0.00	1.0e+00	CCDC17
Schizophrenia (2014)	1.37	2	0	0.0	0.00	1.0e+00	YJEFN3 ZNF318
Type 2 Diabetes (T2D) (2012)	2.39	1	0	0.0	0.00	1.0e+00	CLDN7
Blood Eosinophil Count	1.05	6	1	2.2	-0.97	9.4e-04	AP3M1 CLDN7 DDX6 RGNEF YJEFN3 ZFP36L2
Blood Platelet Count	1.60	9	4	8.9	-0.16	6.8e-01	ABLIM3 AP3M1 CCDC17 CCDC68 DDX6 MMAB YJEFN3 ZFP36L2 ZNF318
Blood Red Count	1.47	4	1	2.2	0.86	1.4e-01	CCDC17 PTK2 YJEFN3 ZFP36L2
Blood White Count	0.96	5	0	0.0	0.00	1.0e+00	CCDC68 DDX6 PTK2 UTP15 ZNF649
Heel T-Score	1.11	4	2	4.4	-0.15	8.1e-01	ARHGEF28 DDX6 ZFP36L2 ZNF318
BMI	1.21	3	0	0.0	0.00	1.0e+00	CCDC17 MMAB ZNF318
Height	0.70	4	3	6.7	0.49	5.1e-01	CCDC17 CLDN7 YJEFN3 ZNF318
Waist Hip Ratio (WHR)	1.43	5	1	2.2	-0.12	8.5e-01	ABLIM3 CLDN7 PTK2 YJEFN3 ZNF318
Systolic Blood Pressure	2.74	4	3	6.7	-0.95	5.4e-02	AP3M1 CLDN7 MMAB ZNF318
Smoking Status	1.36	1	0	0.0	0.00	1.0e+00	PTK2
Allergy or Eczema	1.21	3	0	0.0	0.00	1.0e+00	CCDC17 CCDC68 MMAB
Cardiovascular Disease	2.52	4	2	4.4	-0.63	3.7e-01	AP3M1 RGNEF ZFP36L2 ZNF318
Hypothyroidism (self reported)	1.49	1	0	0.0	0.00	1.0e+00	PTK2
Type 2 Diabetes (T2D) (2018)	0.98	1	0	0.0	0.00	1.0e+00	YJEFN3
Lung FEV1/FVC ratio	1.32	3	0	0.0	0.00	1.0e+00	ABLIM3 CCDC17 CLDN7
Lung FVC	1.52	3	1	2.2	0.00	1.0e+00	ABLIM3 CLDN7 RGNEF
Neuroticism	2.32	3	1	2.2	0.00	1.0e+00	DDX6 MMAB ZNF318
Chronotype (morning person)	0.84	2	0	0.0	0.00	1.0e+00	MMAB ZNF318
Hair Pigment	0.18	3	0	0.0	-0.69	3.1e-01	ARHGEF28 UTP15 YJEFN3
Tanning	0.14	1	0	0.0	0.00	1.0e+00	ZFP36L2
Number of treatments/medications taken	2.33	2	0	0.0	0.00	1.0e+00	ZFP36L2 ZNF318
Sensitivity / hurt feelings	1.80	2	1	2.2	0.00	1.0e+00	DDX6 MMAB
Frequency of depressed mood in last 2 weeks	2.04	1	0	0.0	0.00	1.0e+00	PTK2
Systolic blood pressure, automated reading	2.07	3	1	2.2	0.00	1.0e+00	AP3M1 CLDN7 ZNF318
Diabetes (father)	1.89	1	0	0.0	0.00	1.0e+00	CLDN7
Impedance of leg (right)	1.36	3	1	2.2	0.00	1.0e+00	MMAB PTK2 ZNF318
Leg fat-free mass (left)	0.93	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Trunk fat percentage	0.83	1	0	0.0	0.00	1.0e+00	ZFP36L2
Townsend deprivation index at recruitment	1.95	2	0	0.0	0.00	1.0e+00	MMAB YJEFN3
Maternal smoking around birth	1.60	2	0	0.0	0.00	1.0e+00	CLDN7 MMAB
Fed-up feelings	2.23	2	0	0.0	0.00	1.0e+00	CLDN7 PTK2
Taking other prescription medications	1.64	1	0	0.0	0.00	1.0e+00	ZNF318
Age when periods started (menarche)	0.89	1	0	0.0	0.00	1.0e+00	MMAB
High blood pressure	3.10	5	1	2.2	-0.67	2.1e-01	AP3M1 PTK2 RGNEF ZFP36L2 ZNF318
Hayfever, allergic rhinitis or eczema	1.10	1	0	0.0	0.00	1.0e+00	CCDC68
Medication: Atenolol	1.73	1	0	0.0	0.00	1.0e+00	ZFP36L2
Sitting height	1.31	5	2	4.4	0.03	9.6e-01	CCDC17 DDX6 PTK2 YJEFN3 ZNF318
Chronic bronchitis/emphysema (father)	1.20	1	0	0.0	0.00	1.0e+00	PTK2
High blood pressure (mother)	2.07	2	0	0.0	0.00	1.0e+00	AP3M1 ZNF318
Body mass index (BMI)	1.04	2	0	0.0	0.00	1.0e+00	CCDC17 YJEFN3
Impedance of leg (left)	1.48	3	1	2.2	0.00	1.0e+00	MMAB PTK2 ZNF318
Leg predicted mass (left)	0.92	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Trunk fat mass	0.74	1	0	0.0	0.00	1.0e+00	ZFP36L2
Waist circumference	1.06	1	0	0.0	0.00	1.0e+00	CLDN7
Nervous feelings	1.34	1	0	0.0	0.00	1.0e+00	MMAB
Frequency of tenseness / restlessness in last 2 weeks	1.96	1	1	2.2	0.00	1.0e+00	MMAB
Hearing difficulty/problems with background noise	12.15	12	3	6.7	0.99	6.3e-12	ABLIM3 ANKRA2 AP3M1 ARHGEF28 CCDC68 DDX6 MMAB PTK2 RGNEF UTP15 ZFP36L2 ZNF318
Forced vital capacity (FVC)	1.73	5	1	2.2	-0.70	1.8e-01	ABLIM3 CLDN7 DDX6 RGNEF YJEFN3
Qualifications: None of the above	1.22	1	0	0.0	0.00	1.0e+00	PTK2
Mouth/teeth dental problems	2.35	2	0	0.0	0.00	1.0e+00	MMAB PTK2
Allergy	1.38	2	0	0.0	0.00	1.0e+00	CCDC17 MMAB
Diabetes (self-reported)	1.02	1	0	0.0	0.00	1.0e+00	YJEFN3
Neuroticism score	2.41	4	0	0.0	0.49	5.1e-01	DDX6 MMAB ZFP36L2 ZNF318
Weight	0.78	2	0	0.0	0.00	1.0e+00	DDX6 MMAB
Impedance of arm (right)	0.87	2	0	0.0	0.00	1.0e+00	PTK2 YJEFN3
Arm fat percentage (right)	0.98	3	0	0.0	0.00	1.0e+00	CCDC17 CLDN7 ZFP36L2
Trunk fat-free mass	0.81	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Hip circumference	1.01	2	0	0.0	0.00	1.0e+00	ABLIM3 MMAB
Father's age at death	1.57	1	0	0.0	0.00	1.0e+00	ZFP36L2
Worrier / anxious feelings	1.28	1	0	0.0	0.00	1.0e+00	MMAB
Frequency of tiredness / lethargy in last 2 weeks	2.85	2	1	2.2	0.00	1.0e+00	MMAB ZFP36L2
Falls in the last year	2.03	2	0	0.0	0.00	1.0e+00	MMAB PTK2
Forced expiratory volume in 1-second (FEV1)	1.32	3	1	2.2	0.00	1.0e+00	ABLIM3 CLDN7 DDX6
Mouth/teeth dental problems: Dentures	1.91	2	0	0.0	0.00	1.0e+00	ARHGEF28 PTK2
Forced expiratory volume in 1-second (FEV1), Best measure	1.32	1	0	0.0	0.00	1.0e+00	ABLIM3
Impedance of arm (left)	0.91	2	1	2.2	0.00	1.0e+00	PTK2 YJEFN3
Arm fat mass (right)	0.94	1	0	0.0	0.00	1.0e+00	MMAB
Trunk predicted mass	0.79	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Standing height	0.88	4	2	4.4	-0.06	9.4e-01	CCDC17 DDX6 YJEFN3 ZNF318
Tense / 'highly strung'	1.31	1	0	0.0	0.00	1.0e+00	DDX6
Birth weight of first child	2.68	1	1	2.2	0.00	1.0e+00	PTK2
Peak expiratory flow (PEF)	1.54	4	0	0.0	-0.59	4.1e-01	ABLIM3 CLDN7 MMAB RGNEF
Mouth/teeth dental problems: Bleeding gums	2.51	2	0	0.0	0.00	1.0e+00	MMAB YJEFN3
Medication: Paracetamol	2.35	3	1	2.2	0.00	1.0e+00	MMAB PTK2 ZFP36L2
Gout (self-reported)	1.55	1	0	0.0	0.00	1.0e+00	ZNF318
Hypothyroidism/myxoedema (self-reported)	1.66	2	0	0.0	0.00	1.0e+00	DDX6 PTK2
Medication: Amlodipine	2.22	2	0	0.0	0.00	1.0e+00	AP3M1 ZNF318
Birth weight	3.42	2	1	2.2	0.00	1.0e+00	CLDN7 PTK2
Forced vital capacity (FVC), Best measure	1.73	5	0	0.0	-0.67	2.2e-01	ABLIM3 CLDN7 DDX6 RGNEF YJEFN3
Body fat percentage	0.94	1	0	0.0	0.00	1.0e+00	ZFP36L2
Leg fat percentage (right)	1.25	3	0	0.0	0.00	1.0e+00	CCDC17 CLDN7 ZFP36L2
Arm fat-free mass (right)	0.66	1	0	0.0	0.00	1.0e+00	DDX6
Comparative body size at age 10	1.69	3	0	0.0	0.00	1.0e+00	ARHGEF28 YJEFN3 ZNF318
Worry too long after embarrassment	1.84	1	0	0.0	0.00	1.0e+00	MMAB
Wheeze or whistling in the chest in last year	1.73	2	0	0.0	0.00	1.0e+00	RGNEF ZNF318
Age at first live birth	1.22	1	0	0.0	0.00	1.0e+00	PTK2
Qualifications: College or University degree	1.53	2	1	2.2	0.00	1.0e+00	PTK2 ZNF649
Medication for pain relief, constipation, heartburn	2.19	2	0	0.0	0.00	1.0e+00	PTK2 ZFP36L2
Neck or shoulder pain in last month	1.76	1	0	0.0	0.00	1.0e+00	PTK2
Medication: Blood pressure	2.22	1	0	0.0	0.00	1.0e+00	CLDN7
Medication: Seretide 50 evohaler	2.31	2	0	0.0	0.00	1.0e+00	RGNEF UTP15
Mean time to correctly identify matches	1.92	3	0	0.0	0.00	1.0e+00	AP3M1 CLDN7 YJEFN3
Whole body fat mass	0.83	1	0	0.0	0.00	1.0e+00	ZFP36L2
Leg fat mass (right)	0.95	1	0	0.0	0.00	1.0e+00	ZFP36L2
Arm predicted mass (right)	0.64	1	0	0.0	0.00	1.0e+00	DDX6
Pulse rate, automated reading	1.52	3	0	0.0	0.00	1.0e+00	CCDC17 MMAB UTP15
Alcohol intake frequency.	0.75	1	0	0.0	0.00	1.0e+00	ZNF318
Comparative height size at age 10	0.62	1	0	0.0	0.00	1.0e+00	CCDC17
Number of full sisters	1.60	1	0	0.0	0.00	1.0e+00	AP3M1
Overall health rating	2.05	3	0	0.0	0.00	1.0e+00	PTK2 YJEFN3 ZFP36L2
Chest pain or discomfort	1.18	1	0	0.0	0.00	1.0e+00	CLDN7
Had major operations	1.13	1	0	0.0	0.00	1.0e+00	CCDC17
Medication: Aspirin	2.17	1	0	0.0	0.00	1.0e+00	ZFP36L2
Knee pain experienced in last month	1.92	2	0	0.0	0.00	1.0e+00	AP3M1 PTK2
Hypertension (Self-reported)	2.98	4	1	2.2	-0.65	3.5e-01	AP3M1 PTK2 ZFP36L2 ZNF318
Illnesses of father: Heart disease	1.16	1	0	0.0	0.00	1.0e+00	ZFP36L2
Forced expiratory volume in 1-second (FEV1), predicted	0.94	1	0	0.0	0.00	1.0e+00	YJEFN3
Whole body fat-free mass	0.81	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Leg fat-free mass (right)	0.93	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Arm fat percentage (left)	1.01	2	0	0.0	0.00	1.0e+00	CCDC17 ZFP36L2
Mood swings	2.62	2	1	2.2	0.00	1.0e+00	MMAB PTK2
Loneliness, isolation	1.71	1	0	0.0	0.00	1.0e+00	DDX6
Long-standing illness, disability or infirmity	1.73	1	0	0.0	0.00	1.0e+00	MMAB
Diabetes diagnosed by doctor	1.10	1	0	0.0	0.00	1.0e+00	YJEFN3
Friendships satisfaction	1.28	1	0	0.0	0.00	1.0e+00	ABLIM3
Medication for cholesterol	1.68	1	0	0.0	0.00	1.0e+00	ZNF318
Back pain experienced in last month	1.63	1	0	0.0	0.00	1.0e+00	PTK2
Mineral and other dietary supplements	1.05	1	0	0.0	0.00	1.0e+00	AP3M1
Osteoarthritis (self-reported)	1.86	2	0	0.0	0.00	1.0e+00	CCDC17 PTK2
Medication: Aspirin	2.03	1	0	0.0	0.00	1.0e+00	ZFP36L2
Illnesses of father: None of the above (group 1)	1.49	1	0	0.0	0.00	1.0e+00	AP3M1
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.31	2	0	0.0	0.00	1.0e+00	ABLIM3 RGNEF
Whole body water mass	0.84	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Leg predicted mass (right)	0.93	3	0	0.0	0.00	1.0e+00	DDX6 MMAB PTK2
Arm fat mass (left)	0.89	1	0	0.0	0.00	1.0e+00	ZFP36L2
Number of self-reported non-cancer illnesses	2.37	2	0	0.0	0.00	1.0e+00	ZFP36L2 ZNF318
Average weekly champagne plus white wine intake	1.50	1	0	0.0	0.00	1.0e+00	DDX6
Miserableness	1.81	1	0	0.0	0.00	1.0e+00	MMAB
Hearing aid user	10.37	6	3	6.7	0.97	5.9e-05	ANKRA2 ARHGEF28 CCDC68 PTK2 RGNEF UTP15
Financial situation satisfaction	1.62	1	0	0.0	0.00	1.0e+00	MMAB
Tinnitus: Yes, now most or all of the time	2.45	1	0	0.0	0.00	1.0e+00	ZNF318
Commuting to job workplace: Public transport	1.20	1	0	0.0	0.00	1.0e+00	DDX6
Medication: Blood pressure	3.01	3	1	2.2	0.00	1.0e+00	AP3M1 ZFP36L2 ZNF318
Medication: Bendroflumethiazide	1.71	1	0	0.0	0.00	1.0e+00	ZNF318
Medication: Paracetamol	2.05	2	0	0.0	0.00	1.0e+00	PTK2 ZFP36L2
Illnesses of father: High blood pressure	1.72	1	0	0.0	0.00	1.0e+00	AP3M1
Basal metabolic rate	0.79	2	0	0.0	0.00	1.0e+00	DDX6 MMAB
Leg fat percentage (left)	1.24	3	0	0.0	0.00	1.0e+00	CCDC17 CLDN7 ZFP36L2
Arm fat-free mass (left)	0.69	1	0	0.0	0.00	1.0e+00	DDX6
Irritability	2.20	3	0	0.0	0.00	1.0e+00	CLDN7 MMAB ZFP36L2
Commuting to job workplace: Cycle	2.42	1	0	0.0	0.00	1.0e+00	UTP15
Vascular/heart problems diagnosed by doctor	3.26	5	1	2.2	0.66	2.3e-01	AP3M1 PTK2 RGNEF ZFP36L2 ZNF318
Cholesterol lowering medication	1.15	1	0	0.0	0.00	1.0e+00	ZNF318
Pain experienced in last month	2.47	3	0	0.0	0.00	1.0e+00	MMAB PTK2 ZFP36L2
Alcohol drinker status: Previous	1.70	1	0	0.0	0.00	1.0e+00	PTK2
Impedance of whole body	1.20	4	1	2.2	0.13	8.7e-01	MMAB PTK2 YJEFN3 ZNF318
Leg fat mass (left)	0.90	1	0	0.0	0.00	1.0e+00	ZFP36L2
Arm predicted mass (left)	0.71	1	0	0.0	0.00	1.0e+00	DDX6

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	2	0.057	1.6
GTEx	Adipose Visceral Omentum	1	0.049	1.6
GTEx	Adrenal Gland	0	0.000	1.6
GTEx	Artery Aorta	0	0.000	1.5
GTEx	Artery Coronary	0	0.000	1.6
GTEx	Artery Tibial	1	0.027	1.5
GTEx	Brain Caudate basal ganglia	1	0.109	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.5
GTEx	Brain Cerebellum	1	0.050	1.6
GTEx	Brain Cortex	1	0.097	1.5
GTEx	Brain Frontal Cortex BA9	0	0.000	1.6
GTEx	Brain Hippocampus	0	0.000	1.4
GTEx	Brain Hypothalamus	0	0.000	1.4
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Brain Putamen basal ganglia	0	0.000	1.5
GTEx	Breast Mammary Tissue	1	0.051	1.6
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.5
GTEx	Breast Mammary Tissue (Female)	0	0.000	1.5
GTEx	Cells EBV-transformed lymphocytes	0	0.000	1.6
GTEx	Cells Transformed fibroblasts	1	0.024	1.5
GTEx	Colon Sigmoid	0	0.000	1.6
GTEx	Colon Transverse	0	0.000	1.6
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.5
GTEx	Esophagus Mucosa	2	0.060	1.6
GTEx	Esophagus Muscularis	0	0.000	1.6
GTEx	Heart Atrial Appendage	0	0.000	1.5
GTEx	Heart Left Ventricle	0	0.000	1.6
GTEx	Liver	1	0.139	1.5
GTEx	Lung	0	0.000	1.6
GTEx	Muscle Skeletal	0	0.000	1.6
GTEx	Nerve Tibial	1	0.023	1.6
GTEx	Ovary	0	0.000	1.5
GTEx	Pancreas	1	0.061	1.6
GTEx	Pituitary	0	0.000	1.6
GTEx	Prostate	0	0.000	1.5
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.6
GTEx	Skin Sun Exposed Lower leg	0	0.000	1.6
GTEx	Small Intestine Terminal Ileum	0	0.000	1.5
GTEx	Spleen	0	0.000	1.6
GTEx	Stomach	0	0.000	1.5
GTEx	Testis	0	0.000	1.6
GTEx	Thyroid	0	0.000	1.7
GTEx	Uterus	0	0.000	1.7
GTEx	Vagina	0	0.000	1.4
GTEx	Whole Blood	0	0.000	1.6
METSIM	Adipose	1	0.022	1.5
NTR	Blood	1	0.042	1.5
ROSMAP	Brain Pre-frontal Cortex	2	0.046	1.6
YFS	Blood	1	0.022	1.5
CommonMind	Brain Pre-frontal Cortex	2	0.037	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Breast Invasive Carcinoma	1	0.023	1.4
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	1	0.024	1.4
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	1	0.049	1.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	2	0.046	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	1	0.090	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	2	0.068	1.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	0	0.000	1.5
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	1	0.063	1.6
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	1	0.075	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	3	0.065	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	1	0.145	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	1	0.094	1.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	1.4
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.5
The Cancer Genome Atlas	Thyroid Carcinoma	1	0.019	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.5